DRIO
Income statement / Annual
Last year (2023), DarioHealth Corp.'s total revenue was $20.35 M,
a decrease of 26.41% from the previous year.
In 2023, DarioHealth Corp.'s net income was -$59.43 M.
See DarioHealth Corp.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$20.35 M
|
$27.66 M
|
$20.51 M
|
$7.58 M
|
$7.56 M
|
$7.39 M
|
$5.17 M
|
$2.80 M
|
$823,000.00
|
$51,000.00
|
| Cost of Revenue |
$14.37 M |
$18.00 M |
$16.55 M |
$5.06 M |
$4.96 M |
$5.63 M |
$3.86 M |
$3.36 M |
$1.68 M |
$2.27 M |
| Gross Profit |
$5.98 M |
$9.66 M |
$3.96 M |
$2.51 M |
$2.60 M |
$1.77 M |
$1.31 M |
-$561,000.00 |
-$855,000.00 |
-$2.22 M |
| Gross Profit Ratio |
0.29 |
0.35 |
0.19 |
0.33 |
0.34 |
0.24 |
0.25 |
-0.2 |
-1.04 |
-43.59 |
| Research and Development
Expenses |
$20.25 M
|
$19.65 M
|
$17.22 M
|
$4.43 M
|
$3.69 M
|
$3.68 M
|
$3.30 M
|
$2.15 M
|
$2.57 M
|
$3.94 M
|
| General & Administrative
Expenses |
$18.14 M
|
$16.49 M
|
$23.53 M
|
$12.76 M
|
$5.48 M
|
$5.47 M
|
$4.73 M
|
$3.38 M
|
$2.95 M
|
$3.64 M
|
| Selling & Marketing
Expenses |
$23.79 M
|
$30.32 M
|
$39.71 M
|
$15.23 M
|
$11.13 M
|
$10.31 M
|
$7.71 M
|
$4.74 M
|
$1.33 M
|
$1.06 M
|
| Selling, General &
Administrative Expenses |
$41.80 M
|
$46.82 M
|
$63.24 M
|
$27.98 M
|
$16.61 M
|
$15.78 M
|
$12.43 M
|
$8.12 M
|
$4.28 M
|
$4.70 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$62.17 M |
$66.47 M |
$80.46 M |
$32.42 M |
$20.30 M |
$19.45 M |
$15.73 M |
$10.27 M |
$6.84 M |
$8.65 M |
| Cost And Expenses |
$76.54 M |
$84.47 M |
$97.01 M |
$37.48 M |
$25.26 M |
$25.08 M |
$19.59 M |
$13.64 M |
$8.52 M |
$10.92 M |
| Interest Income |
$1.87 M |
$506,000.00 |
$44,000.00 |
$61,000.00 |
$16,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$645,000.00 |
$1.88 M |
$84,000.00 |
$49,000.00 |
$27,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$4.99 M
|
$3.80 M
|
$3.53 M
|
$457,000.00
|
$551,000.00
|
$207,000.00
|
$195,000.00
|
$387,000.00
|
$335,000.00
|
$549,000.00
|
| EBITDA |
-$53.49 M
|
-$56.81 M
|
-$73.12 M
|
-$29.71 M
|
-$17.52 M
|
-$17.48 M
|
-$14.22 M
|
-$10.45 M
|
-$7.36 M
|
-$10.32 M
|
| EBITDA Ratio |
-2.63 |
-1.89 |
-3.56 |
-3.98 |
-2.32 |
-2.35 |
-2.53 |
-3.71 |
-9.65 |
-235.14 |
| Operating Income Ratio
|
-2.76
|
-2.05
|
-3.73
|
-3.95
|
-2.34
|
-2.39
|
-2.79
|
-3.96
|
-9.35
|
-222.71
|
| Total Other
Income/Expenses Net |
-$3.17 M
|
-$5.38 M
|
-$235,000.00
|
$458,000.00
|
-$31,000.00
|
-$115,000.00
|
-$1.32 M
|
$214,000.00
|
$556,000.00
|
-$1.52 M
|
| Income Before Tax |
-$59.36 M |
-$62.19 M |
-$76.73 M |
-$29.45 M |
-$17.74 M |
-$17.80 M |
-$15.74 M |
-$10.89 M |
-$7.14 M |
-$12.88 M |
| Income Before Tax Ratio
|
-2.92
|
-2.25
|
-3.74
|
-3.89
|
-2.35
|
-2.41
|
-3.05
|
-3.88
|
-8.68
|
-252.49
|
| Income Tax Expense |
$64,000.00 |
$4,000.00 |
$32,000.00 |
-$458,000.00 |
$31,000.00 |
-$115,000.00 |
$1.32 M |
$55,000.00 |
-$556,000.00 |
$2.01 M |
| Net Income |
-$59.43 M |
-$62.19 M |
-$76.76 M |
-$28.99 M |
-$17.77 M |
-$17.80 M |
-$15.74 M |
-$10.89 M |
-$7.14 M |
-$12.88 M |
| Net Income Ratio |
-2.92 |
-2.25 |
-3.74 |
-3.83 |
-2.35 |
-2.41 |
-3.05 |
-3.88 |
-8.68 |
-252.49 |
| EPS |
-1.93 |
-2.63 |
-4.63 |
-4.86 |
-7.84 |
-15.21 |
-32.7 |
-41.85 |
-75.27 |
-534.14 |
| EPS Diluted |
-1.93 |
-2.63 |
-4.63 |
-4.86 |
-7.84 |
-15.21 |
-32.7 |
-41.85 |
-75.27 |
-534.14 |
| Weighted Average Shares
Out |
$28.37 M
|
$23.64 M
|
$16.59 M
|
$5.96 M
|
$2.27 M
|
$1.17 M
|
$481,412.00
|
$260,148.00
|
$94,887.00
|
$24,108.00
|
| Weighted Average Shares
Out Diluted |
$28.37 M
|
$23.64 M
|
$16.59 M
|
$5.96 M
|
$2.27 M
|
$1.17 M
|
$481,412.00
|
$260,148.00
|
$94,887.00
|
$24,108.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
